Hytrin (Terazosin)

Terazosin selectively blocks alpha‑1 adrenergic receptors on vascular smooth muscle and in the prostate. This blockade prevents norepinephrine‑induced contraction, causing blood vessels to dilate and reducing peripheral resistance, which lowers blood pressure. In the prostate, it relaxes smooth muscle, easing urinary flow.

The appropriate dose of Hytrin is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for terazosin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To request Hytrin, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hytrin (terazosin) shares the same class mechanism as other alpha‑1 antagonists such as doxazosin and tamsulosin. While all lower blood pressure and relax prostatic smooth muscle, individual agents differ in selectivity, dosing frequency, and side‑effect profiles. Choice of therapy depends on patient‑specific factors and clinician judgment.

Hytrin should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Hytrin is taken orally, usually with a full glass of water. It can be taken with or without food, but consistency with meals may help reduce dizziness. Patients should swallow the tablet whole and not crush or chew it.

The most serious risks include severe orthostatic hypotension, which can lead to fainting, and priapism, a prolonged painful erection that requires urgent medical care. Patients should report sudden drops in blood pressure, fainting episodes, or any persistent erection to a healthcare professional immediately.

Hytrin is contraindicated in patients with known hypersensitivity to terazosin or any component of the formulation. Caution is advised for individuals with severe liver disease, uncontrolled heart failure, or those taking phosphodiesterase‑5 inhibitors, as the combination can cause dangerous blood‑pressure drops.